Cargando…

Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!

Detalles Bibliográficos
Autores principales:	Guiu, Boris, Assenat, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812160/ https://www.ncbi.nlm.nih.gov/pubmed/33490205 http://dx.doi.org/10.21037/atm-2020-131

Ejemplares similares

Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
por: Shing, Kit, et al.
Publicado: (2020)

Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice
por: Celsa, Ciro, et al.
Publicado: (2023)

Uni-, Bi- or Trifocal Hepatocellular Carcinoma in Western Patients: Recurrence and Survival after Percutaneous Thermal Ablation
por: Preel, Ancelin, et al.
Publicado: (2021)

Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients
por: Hermida, Margaux, et al.
Publicado: (2020)

Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery
por: Meerun, Mohamad Azhar, et al.
Publicado: (2022)

Combination therapy of transcatheter arterial chemoembolization with axitinib for the treatment of inoperable hepatocellular carcinoma
por: Nouso, Kazuhiro, et al.
Publicado: (2020)

A new era for hepatocellular carcinoma
por: Memeo, Riccardo, et al.
Publicado: (2023)

Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma
por: Herrero, Astrid, et al.
Publicado: (2022)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Ethical implications of HIV self-testing: the game is far from being over
por: Bain, Luchuo Engelbert, et al.
Publicado: (2016)

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
por: Campani, Claudia, et al.
Publicado: (2020)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
por: Mendiratta-Lala, Mishal, et al.
Publicado: (2023)

Games People Play: Lessons on Performance Measure Gaming from New Zealand Comment on "Gaming New Zealand’s Emergency Department Target: How and Why Did It Vary Over Time and Between Organisations?"
por: Lines, Lisa M.
Publicado: (2020)

The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future
por: Woo, Hyun Young, et al.
Publicado: (2020)

Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
por: Oh, Hyunwoo, et al.
Publicado: (2020)

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Lipids link immune suppression to effective immunotherapy in steatotic hepatocellular carcinoma
por: Li, Bing, et al.
Publicado: (2023)

May an aspirin a day truly take hepatocellular carcinoma away?
por: Giannini, Edoardo G., et al.
Publicado: (2023)

Camrelizumab—targeting a novel PD-1 epitope to treat hepatocellular carcinoma
por: Rakké, Yannick Sebastiaan, et al.
Publicado: (2020)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma
por: Cantaloube, Marie, et al.
Publicado: (2021)

A large randomized clinical trial is necessary to establish the role of camrelizumab in hepatocellular carcinoma
por: Ravindran, Nishal, et al.
Publicado: (2020)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

Anti-PD1 monotherapy in hepatocellular carcinoma: a step forward or already behind?
por: Catanese, Silvia, et al.
Publicado: (2020)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A
por: Lippert, Trenton, et al.
Publicado: (2023)

Microwave ablation in solitary hepatocellular carcinoma within 3–5 cm requiring consideration
por: Jiang, Lingmin, et al.
Publicado: (2023)

Beyond playing games: nephrologist vs machine in pediatric dialysis prescribing
por: Hayes, Wesley, et al.
Publicado: (2018)

Peptide vaccines for hepatocellular carcinoma
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib—time has come for a better approach
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

Is there a role for stereotactic body radiation before immune checkpoint inhibitor therapy for advanced hepatocellular carcinoma?
por: Mukherjee, Sandeep
Publicado: (2023)

Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinoma
por: Lim, Jhin Jieh, et al.
Publicado: (2022)

Cancer stem cells in hepatocellular carcinomas
por: Das, Prasenjit, et al.
Publicado: (2015)

Time to stop using hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma?—the SCOOP-2 trial experience
por: Peck-Radosavljevic, Markus, et al.
Publicado: (2020)

Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
por: Numata, Kazushi
Publicado: (2021)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Commentary: Patch repair for aortomitral endocarditis: Playing the short game or the long game?
por: Hirji, Sameer A., et al.
Publicado: (2020)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5582o7ircmc79rv1cft4dbh6pk